Some researchers believe DMT, a powerful psychedelic that may naturally occur in the brain, could be your soul’s “ferryman.” ...

that is advancing a psychedelic program investigating a proprietary form of sub-psychedelic DMT for stroke and traumatic brain injury. www.algernonpharmaceuticals.com. The CSE does not accept ...

that is advancing a psychedelic program investigating a proprietary form of sub-psychedelic DMT for stroke and traumatic brain injury. [email protected] [email protected ...

that is advancing a psychedelic program investigating a proprietary form of sub-psychedelic DMT for stroke and traumatic brain injury. www.algernonpharmaceuticals.com. The CSE does not accept ...

that is advancing a psychedelic program investigating a proprietary form of sub-psychedelic DMT for stroke and traumatic brain injury. Neither the Canadian Securities Exchange nor its Market Regulator ...

placebo-controlled Phase 2a DMT study of 40 stroke patients in Europe. The study is expected to begin enrolling patients in Q3 of 2025. Validcare is a leading U.S. based full service CRO with ...

that is advancing a psychedelic program investigating a proprietary form of sub-psychedelic DMT for stroke and traumatic brain injury. Christopher J. MoreauCEOAlgernon Pharmaceuticals Inc.604.398.4175 ...

I set out on a 3 ½-week trip to Japan. The timing worked out — the favorable dollar-to-yen exchange rate, mild weather, and vibrant autumn foliage made it a great time to visit. With little ...

“I don’t know, is he going?” Trump asked reporters in Washington shortly before the trip. “I don’t know, I mean I really don’t. Because, if he was going to be there, it would be cheaper.

A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the ...